Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $1.33 Million - $1.71 Million
-28,600 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$47.2 - $67.81 $1.35 Million - $1.94 Million
28,600 New
28,600 $1.5 Million
Q4 2020

Feb 16, 2021

SELL
$18.53 - $31.5 $55,590 - $94,500
-3,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$14.68 - $19.12 $44,040 - $57,360
3,000 New
3,000 $57,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.